Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Inventiva S.A
IVA | US
5.15
USD-0.06
-1.15%
IVA | US
Loading StockChartView...
About Inventiva S.A
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
24/04/2026
Close
5.15
Open
5.14
High
5.26
Low
5.11
Inventiva S.A. a clinical-stage biopharmaceutical company focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix France.
View LessIVA | US
Risk
60.2
Sharpe
0.32
Luna's Score
36/100
Recommendation
Sell
Luna says (IVA | US)
What's Working
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
67.9%1 month
60.2%3 months
54.3%6 months
79.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.10
Debt to equity
-1.15
Debt to assets
0.54
Ent. to EBITDA
-1.34
Ent. to rev.
5.65
PEG
-
Other Fundamentals
EBITDA
-98.36M
MarketCap
271.66M
MarketCap(USD)
271.66M
Div. yield
-
Op. margin
-1.91K
Erngs. growth
-
Rev. growth
-58.70
Ret. on equity
-1.64K
Short ratio
14.15
Short perc.
0.46
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.87
Range1M
1.31
Range3M
2.36
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.64
Price X volume
1.53M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.34 | 0.53 | Cheaper |
| Ent. to Revenue | 5.65 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.10 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 54.34 | 72.80 | Lower Risk |
| Debt to Equity | -1.15 | -1.23 | Cheaper |
| Debt to Assets | 0.54 | 0.25 | Expensive |
| Market Cap | 271.66M | 3.66B | Emerging |
